Emiliano Calvo

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 38

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature medicine

Nature communications

Cancers

START Madrid

This page only lists publications with an associated author ORCID identifier.

Affiliation History

START Madrid Jul 01 2008

Spain

Director, Clinical Research :: Early Phase Clinical Drug Development in Oncology

Vall d'Hebron Research Institute

Spain

Co-Director :: Early Phase (Phase 1) Clinical Drug Development, Oncology

Publications

Alexander W Wyatt, Saskia Litière, Francois-Clement Bidard, Luc Cabel, Lars Dyrskjøt, Chris A Karlovich, Klaus Pantel, Joan Petrie, Reena Philip, Hillary S Andrews, Paz J Vellanki, Sofie H Tolmeijer, Xenia Villalobos Alberu, Christian Alfano, Jan Bogaerts, Emiliano Calvo, Helen X Chen, Rodrigo De Almeida Toledo, Elisabeth G E de Vries, Lesley Seymour, Scott A Laurie, Elena Garralda
Plasma ctDNA as a treatment response biomarker in metastatic cancers: evaluation by the RECIST working group. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Elena Garralda, Marie-Eve Beaulieu, Victor Moreno, Sílvia Casacuberta-Serra, Sandra Martínez-Martín, Laia Foradada, Guzman Alonso, Daniel Massó-Vallés, Sergio López-Estévez, Toni Jauset, Elena Corral de la Fuente, Bernard Doger, Tatiana Hernández, Raquel Perez-Lopez, Oriol Arqués, Virginia Castillo Cano, Josefa Morales, Jonathan R Whitfield, Manuela Niewel, Laura Soucek, Emiliano Calvo
MYC targeting by OMO-103 in solid tumors: a phase 1 trial. Nature medicine 30 (3) (2024)
Neil H Segal, Ignacio Melero Bermejo, Victor Moreno, Neeltje Steeghs, Aurélien Marabelle, Kristoffer Staal Rohrberg, Maria E Rodriguez-Ruiz, Joseph P Eder, Cathy Eng, Gulam A Manji, Daniel Waterkamp, Barbara Leutgeb, Said Bouseida, Nick Flinn, Meghna Das Thakur, Markus C Elze, Hartmut Koeppen, Candice Jamois, Meret Martin-Facklam, Christopher H Lieu, Emiliano Calvo, Luis Paz-Ares, Josep Tabernero, Guillem Argilés
CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials. Nature communications 15 (1) (2024)
Elena Garralda, Marie-Eve Beaulieu, Victor Moreno, Sílvia Casacuberta-Serra, Sandra Martínez-Martín, Laia Foradada, Guzman Alonso, Daniel Massó-Vallés, Sergio López-Estévez, Toni Jauset, Elena Corral de la Fuente, Bernard Doger, Tatiana Hernández, Raquel Perez-Lopez, Oriol Arqués, Virginia Castillo Cano, Josefa Morales, Jonathan R Whitfield, Manuela Niewel, Laura Soucek, Emiliano Calvo
MYC targeting by OMO-103 in solid tumors: a phase 1 trial. Nature medicine 30 (3) (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Elena Garralda, Marie-Eve Beaulieu, Victor Moreno, Sílvia Casacuberta-Serra, Sandra Martínez-Martín, Laia Foradada, Guzman Alonso, Daniel Massó-Vallés, Sergio López-Estévez, Toni Jauset, Elena Corral de la Fuente, Bernard Doger, Tatiana Hernández, Raquel Perez-Lopez, Oriol Arqués, Virginia Castillo Cano, Josefa Morales, Jonathan R Whitfield, Manuela Niewel, Laura Soucek, Emiliano Calvo
MYC targeting by OMO-103 in solid tumors: a phase 1 trial. Nature medicine 30 (3) (2024)
Neil H Segal, Ignacio Melero Bermejo, Victor Moreno, Neeltje Steeghs, Aurélien Marabelle, Kristoffer Staal Rohrberg, Maria E Rodriguez-Ruiz, Joseph P Eder, Cathy Eng, Gulam A Manji, Daniel Waterkamp, Barbara Leutgeb, Said Bouseida, Nick Flinn, Meghna Das Thakur, Markus C Elze, Hartmut Koeppen, Candice Jamois, Meret Martin-Facklam, Christopher H Lieu, Emiliano Calvo, Luis Paz-Ares, Josep Tabernero, Guillem Argilés
CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials. Nature communications 15 (1) (2024)
Elena Garralda, Marie-Eve Beaulieu, Victor Moreno, Sílvia Casacuberta-Serra, Sandra Martínez-Martín, Laia Foradada, Guzman Alonso, Daniel Massó-Vallés, Sergio López-Estévez, Toni Jauset, Elena Corral de la Fuente, Bernard Doger, Tatiana Hernández, Raquel Perez-Lopez, Oriol Arqués, Virginia Castillo Cano, Josefa Morales, Jonathan R Whitfield, Manuela Niewel, Laura Soucek, Emiliano Calvo
MYC targeting by OMO-103 in solid tumors: a phase 1 trial. Nature medicine 30 (3) (2024)
Irene Moreno-Candilejo, Tatiana Hernández, Emiliano Calvo, Salvador Fudio, Carmen Kahatt, Cristian Fernández, Jorge Luis Iglesias, Gema Corral, Laura Pérez-Ramos, Lola Montilla, Ali Zeaiter, Rubin Lubomirov
Impact of a Moderate CYP3A4 Inducer (Bosentan) on Lurbinectedin Pharmacokinetics and Safety in Patients with Advanced Solid Tumors: An Open-Label, Two-Way, Crossover, Phase Ib Drug-Drug Interaction Study. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Elena Garralda, Marie-Eve Beaulieu, Victor Moreno, Sílvia Casacuberta-Serra, Sandra Martínez-Martín, Laia Foradada, Guzman Alonso, Daniel Massó-Vallés, Sergio López-Estévez, Toni Jauset, Elena Corral de la Fuente, Bernard Doger, Tatiana Hernández, Raquel Perez-Lopez, Oriol Arqués, Virginia Castillo Cano, Josefa Morales, Jonathan R Whitfield, Manuela Niewel, Laura Soucek, Emiliano Calvo
MYC targeting by OMO-103 in solid tumors: a phase 1 trial. Nature medicine (2024)
Neil H Segal, Ignacio Melero Bermejo, Victor Moreno, Neeltje Steeghs, Aurélien Marabelle, Kristoffer Staal Rohrberg, Maria E Rodriguez-Ruiz, Joseph P Eder, Cathy Eng, Gulam A Manji, Daniel Waterkamp, Barbara Leutgeb, Said Bouseida, Nick Flinn, Meghna Das Thakur, Markus C Elze, Hartmut Koeppen, Candice Jamois, Meret Martin-Facklam, Christopher H Lieu, Emiliano Calvo, Luis Paz-Ares, Josep Tabernero, Guillem Argilés
CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials. Nature communications 15 (1) (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Neil H Segal, Ignacio Melero Bermejo, Victor Moreno, Neeltje Steeghs, Aurélien Marabelle, Kristoffer Staal Rohrberg, Maria E Rodriguez-Ruiz, Joseph P Eder, Cathy Eng, Gulam A Manji, Daniel Waterkamp, Barbara Leutgeb, Said Bouseida, Nick Flinn, Meghna Das Thakur, Markus C Elze, Hartmut Koeppen, Candice Jamois, Meret Martin-Facklam, Christopher H Lieu, Emiliano Calvo, Luis Paz-Ares, Josep Tabernero, Guillem Argilés
CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials. Nature communications 15 (1) (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I trial of viral vector based personalized vaccination elicits robust neoantigen specific antitumor T cell responses. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Irene Moreno-Candilejo, Tatiana Hernández, Emiliano Calvo, Salvador Fudio, Carmen Kahatt, Cristian Fernández, Jorge Luis Iglesias, Gema Corral, Laura Pérez-Ramos, Lola Montilla, Ali Zeaiter, Rubin Lubomirov
Impact of a Moderate CYP3A4 Inducer (Bosentan) on Lurbinectedin Pharmacokinetics and Safety in Patients with Advanced Solid Tumors: An Open-Label, Two-Way, Crossover, Phase Ib Drug-Drug Interaction Study. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Elena Garralda, Marie-Eve Beaulieu, Victor Moreno, Sílvia Casacuberta-Serra, Sandra Martínez-Martín, Laia Foradada, Guzman Alonso, Daniel Massó-Vallés, Sergio López-Estévez, Toni Jauset, Elena Corral de la Fuente, Bernard Doger, Tatiana Hernández, Raquel Perez-Lopez, Oriol Arqués, Virginia Castillo Cano, Josefa Morales, Jonathan R Whitfield, Manuela Niewel, Laura Soucek, Emiliano Calvo
MYC targeting by OMO-103 in solid tumors: a phase 1 trial. Nature medicine 30 (3) (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Neil H Segal, Ignacio Melero Bermejo, Victor Moreno, Neeltje Steeghs, Aurélien Marabelle, Kristoffer Staal Rohrberg, Maria E Rodriguez-Ruiz, Joseph P Eder, Cathy Eng, Gulam A Manji, Daniel Waterkamp, Barbara Leutgeb, Said Bouseida, Nick Flinn, Meghna Das Thakur, Markus C Elze, Hartmut Koeppen, Candice Jamois, Meret Martin-Facklam, Christopher H Lieu, Emiliano Calvo, Luis Paz-Ares, Josep Tabernero, Guillem Argilés
CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials. Nature communications 15 (1) (2024)
Elena Garralda, Marie-Eve Beaulieu, Victor Moreno, Sílvia Casacuberta-Serra, Sandra Martínez-Martín, Laia Foradada, Guzman Alonso, Daniel Massó-Vallés, Sergio López-Estévez, Toni Jauset, Elena Corral de la Fuente, Bernard Doger, Tatiana Hernández, Raquel Perez-Lopez, Oriol Arqués, Virginia Castillo Cano, Josefa Morales, Jonathan R Whitfield, Manuela Niewel, Laura Soucek, Emiliano Calvo
MYC targeting by OMO-103 in solid tumors: a phase 1 trial. Nature medicine 30 (3) (2024)
Lucía Paniagua-Herranz, Bernard Doger, Cristina Díaz-Tejeiro, Adrian Sanvicente, Cristina Nieto-Jiménez, Victor Moreno, Pedro Pérez Segura, Gyorffy Balazs, Emiliano Calvo, Alberto Ocaña
Genomic Mapping of Epidermal Growth Factor Receptor and Mesenchymal-Epithelial Transition-Up-Regulated Tumors Identifies Novel Therapeutic Opportunities. Cancers 15 (12) (2023)
Tatiana Hernández, Natalia Baños, Laura Del Puerto Nevado, Ignacio Mahillo Fernández, Bernard Doger De-Speville, Emiliano Calvo, Michael Wick, Jesús García-Foncillas, Victor Moreno
Patient Characteristics Associated with Growth of Patient-Derived Tumor Implants in Mice (Patient-Derived Xenografts). Cancers 15 (22) (2023)
Ignacio Melero Bermejo, Tamara Tanos, Mariana Bustamante, Miguel F Sanmamed, Emiliano Calvo, Irene Moreno-Candilejo, Victor Moreno, Tatiana Hernández, Maria Martinez-García, Alejo Rodriguez-Vida, Josep Tabernero, Analia Azaro, Mariano Ponz-Sarvisé, Iben Spanggaard, Kristoffer Staal Rohrberg, Ernesto Guarin, Eveline Nüesch, Iakov I Davydov, Chia-Huey Ooi, José Duarte, Evelyne Chesne, Christine McIntyre, Maurizio Ceppi, Marta Cañamero, Oliver Krieter
A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors. Science translational medicine 15 (695) (2023)
Funda Meric-Bernstam, Emiliano Calvo, Keun Seok Lee, Victor Moreno, Yeon Hee Park, Sun Young Rha, Pavani Chalasani, Wei Zhong, Diansong Zhou, Steven R Pirie-Shepherd, Abraham Cf Leung, Curigliano Giuseppe
Safety and Tolerability of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients With HER2-Expressing Solid Tumors: A Phase 1 Dose Escalation Study. Molecular cancer therapeutics (2023)
Lucía Paniagua-Herranz, Bernard Doger, Cristina Díaz-Tejeiro, Adrian Sanvicente, Cristina Nieto-Jiménez, Victor Moreno, Pedro Pérez Segura, Gyorffy Balazs, Emiliano Calvo, Alberto Ocaña
Genomic Mapping of Epidermal Growth Factor Receptor and Mesenchymal-Epithelial Transition-Up-Regulated Tumors Identifies Novel Therapeutic Opportunities. Cancers 15 (12) (2023)
Ignacio Melero Bermejo, Tamara Tanos, Mariana Bustamante, Miguel F Sanmamed, Emiliano Calvo, Irene Moreno-Candilejo, Victor Moreno, Tatiana Hernández, Maria Martinez-García, Alejo Rodriguez-Vida, Josep Tabernero, Analia Azaro, Mariano Ponz-Sarvisé, Iben Spanggaard, Kristoffer Staal Rohrberg, Ernesto Guarin, Eveline Nüesch, Iakov I Davydov, Chia-Huey Ooi, José Duarte, Evelyne Chesne, Christine McIntyre, Maurizio Ceppi, Marta Cañamero, Oliver Krieter
A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors. Science translational medicine 15 (695) (2023)
Stephen K Tahir, Emiliano Calvo, Benedito Arruda Carneiro, Junichiro Yuda, Aditya V Shreenivas, Mojca Jongen-Lavrencic, Eelke H Gort, Kenichi Ishizawa, Daniel Morillo, Carla Biesdorf, Morey Smith, Dong Cheng, Monica Motwani, David Sharon, Tamar Uziel, Dimple A Modi, Fritz G Buchanan, Susan Morgan-Lappe, Bruno C Medeiros, Darren C Phillips
Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia. Blood (2023)
Stephen K Tahir, Emiliano Calvo, Benedito Arruda Carneiro, Junichiro Yuda, Aditya V Shreenivas, Mojca Jongen-Lavrencic, Eelke H Gort, Kenichi Ishizawa, Daniel Morillo, Carla Biesdorf, Morey Smith, Dong Cheng, Monica Motwani, David Sharon, Tamar Uziel, Dimple A Modi, Fritz G Buchanan, Susan Morgan-Lappe, Bruno C Medeiros, Darren C Phillips
Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia. Blood (2023)
Enriqueta Felip, Victor Moreno, Daniel Morgensztern, Giuseppe Curigliano, Piotr Rutkowski, José Manuel Trigo, Aitana Calvo, Dariusz Kowalski, Diego Cortinovis, Ruth Plummer, Michele Maio, Paolo A Ascierto, Vladimir I Vladimirov, Andres Cervantes, Enrique Zudaire, Anasuya Hazra, Huybrecht T'jollyn, Nibedita Bandyopadhyay, James G Greger, Edward Attiyeh, Hong Xie, Emiliano Calvo
First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers. Cancer chemotherapy and pharmacology 89 (4) (2022)
Alexander Muik, Elena Garralda, Isil Altintas, Friederike Gieseke, Ravit Geva, Eytan Ben-Ami, Corinne Maurice-Dror, Emiliano Calvo, Patricia M LoRusso, Guzman Alonso, Maria E Rodriguez-Ruiz, Kristina B Schoedel, Jordan M Blum, Bianca Sänger, Theodora W Salcedo, Saskia M Burm, Eliana Stanganello, Dennis Verzijl, Fulvia Vascotto, Angelica Sette, Juliane Quinkhardt, Theo S Plantinga, Aras Toker, Edward N van den Brink, Mark Fereshteh, Mustafa Diken, David Satijn, Sebastian Kreiter, Esther C W Breij, Gaurav Bajaj, Eleni Lagkadinou, Kate Sasser, Özlem Türeci, Ulf Forssmann, Tahamtan Ahmadi, Uğur Şahin, Maria Jure-Kunkel, Ignacio Melero Bermejo
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors. Cancer discovery 12 (5) (2022)
Geriletu Ao, Maria de Miguel, Ana Gomes, Runhan Liu, Valentina Boni, Irene Moreno, José Miguel Cárdenas, Antonio Cubillo, Lisardo Ugidos, Emiliano Calvo
Toxicity and antitumor activity of novel agents in elderly patients with cancer included in phase 1 studies. Investigational new drugs 39 (6) (2021)
Michael L Maitland, Jasgit C Sachdev, Manish R Sharma, Victor Moreno, Valentina Boni, Shivaani Kummar, Erica Stringer-Reasor, Nehal Lakhani, Allison R Moreau, Dawei Xuan, Ray Li, Eric L Powell, Amy Jackson-Fisher, Michelle Bowers, Shilpa Alekar, Xiaohua Xin, Anthony W Tolcher, Emiliano Calvo
First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody-Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (16) (2021)
María Eugenia Olmedo, Martin Forster, Victor Moreno, María Pilar López-Criado, Irene Braña, Michael Flynn, Bernard Doger, María de Miguel, José Antonio López-Vilariño, Rafael Núñez, Carmen Kahatt, Martin Cullell-Young, Ali Zeaiter, Emiliano Calvo
Efficacy and safety of lurbinectedin and doxorubicin in relapsed small cell lung cancer. Results from an expansion cohort of a phase I study. Investigational new drugs 39 (5) (2021)
Martin Smoragiewicz, Alex A Adjei, Emiliano Calvo, Josep Tabernero, Aurélien Marabelle, Christophe Massard, Jun Tang, Elisabeth G E de Vries, Jean Yves Douillard, Lesley Seymour, null null
Design and Conduct of Early Clinical Studies of Immunotherapy: Recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies 2019 (MDICT). Clinical cancer research : an official journal of the American Association for Cancer Research 26 (11) (2020)
Sara M Tolaney, Young-Hyuck Im, Emiliano Calvo, Yen-Shen Lu, Erika Hamilton, Andres Forero-Torres, Thomas Bachelot, Michela Maur, Angelica Fasolo, Ralph Tiedt, Lisa Nardi, Uz Stammberger, Ahmed M Abdelhady, Shiling Ruan, Soo Chin Lee
Phase Ib Study of Ribociclib plus Fulvestrant and Ribociclib plus Fulvestrant plus PI3K Inhibitor (Alpelisib or Buparlisib) for HR+ Advanced Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (2) (2020)
Maria de Miguel, Bernard Doger, Valentina Boni, Tatiana Hernández-Guerrero, Irene Moreno, Daniel Morillo, Victor Moreno, Emiliano Calvo
Increased vulnerability of clinical research units during the COVID-19 crisis and their protection. Cancer 126 (17) (2020)
Ian Chau, Nicolas Penel, Andres O Soriano, Hendrick-Tobias Arkenau, Jennifer Cultrera, Rafael Santana-Davila, Emiliano Calvo, Christophe Le Tourneau, Lars Zender, Johanna C Bendell, Gu Mi, Ling Gao, Samuel Clark McNeely, Joana M Oliveira, David Ferry, Roy S Herbst, Charles S Fuchs
Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial. Cancers 12 (10) (2020)
Maria J de Miguel Luken, Pablo Umana, Ana Luiza Gomes de Morais, Victor Moreno, Emiliano Calvo
T-cell-engaging Therapy for Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (6) (2020)

Emiliano Calvo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Emiliano Calvo